Small cell lung cancer transformation during antitumor therapies: A systematic review
Lung cancer is the most common cause of cancer-related death. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major histological categories of lung cancers. Drug resistance is a great challenge for cancer treatment, and histological transformation from NSCLC to SCLC...
Main Authors: | Chai Xing, Zhang Xinru, Li Wenqian, Chai Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-08-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2021-0321 |
Similar Items
-
Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
by: Takuma Imakita, et al.
Published: (2017-01-01) -
Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
by: Isa Mambetsariev, et al.
Published: (2022-03-01) -
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review
by: Alessandro Leonetti, et al.
Published: (2021-04-01) -
Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC
by: Xinlin Liang, et al.
Published: (2022-05-01) -
Overcoming T790M mutant small cell lung cancer with the third‐generation EGFR‐TKI osimertinib
by: Kejing Tang, et al.
Published: (2019-02-01)